Correction: Blood transcriptional profiling reveals IL-1 and integrin signaling pathways associated with clinical response to extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma

Zuolin Ying; Lisa Shiue; Katherine Park; Jutta Kollet; Pedram Bijani; Meghali Goswami; Madeleine Duvic; Xiao Ni

doi:10.18632/oncotarget.27197

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Blood transcriptional profiling reveals IL-1 and integrin signaling pathways associated with clinical response to extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma

PDF | How to cite

Oncotarget. 2019; 10:5492-5492. https://doi.org/10.18632/oncotarget.27197

Metrics: PDF 1203 views | ?

Zuolin Ying¹, Lisa Shiue¹, Katherine Park¹, Jutta Kollet², Pedram Bijani¹, Meghali Goswami¹, Madeleine Duvic¹ and Xiao Ni¹

¹ Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
² Bioinformatics, Miltenyi Biotec GmbH, Bergisch Gladbach, 51429, Germany

Published: September 10, 2019

This article has been corrected: The #2 affiliation information has been updated. The proper institution name is shown below:

²Bioinformatics, Miltenyi Biotec GmbH, Bergisch Gladbach, 51429, Germany

Original article: Oncotarget. 2019; 10:3183–3197. DOI: https://doi.org/10.18632/oncotarget.26900.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27197

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: Blood transcriptional profiling reveals IL-1 and integrin signaling pathways associated with clinical response to extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma